Tag: https://www.bio.org/events/bio-international-convention
Genetic Medicines’ Path to Scalability for Patients and Investors source
Opportunities for Financing Your Company Through Series B and Beyond source
Tackling Challenges in Oncology Drug Discovery and Development source
Connecting Investors and Patient Advocacy Groups: An Overview of Funding New Therapies source
Policy Outlook: Understanding the Environment for Pricing and Access to Medicines During an Election Year. source
AI within Biopharma: Separating Value from Hype source
The Next Frontier for Metabolic and Obesity Treatments. source
Congressman Drew Ferguson (R-GA) discusses AMR and the PASTEUR Act with Dr. Stephen Schondelmeyer, Director of the PRIME Institute, University of Minnesota’s College of Pharmacy at the House Ways & Means Committee Hearing on Examining Chronic Drug Shortages in the United States. (Feb. 6, 2024) source
The House Committee on Oversight and Accountability held a markup on a series of legislation including H.R. 6283, the Delinking Revenue from Unfair Gouging (DRUG) Act. In opening remarks on H.R.6283, Chair James Comer (R-KY) spoke to the importance of increasing transparency among the role of pharmacy benefit managers (PBMs) specifically within the Federal Employees […]